Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy

Starting soon · Not applicable

Conditions studied: Locally Advanced Cervical Cancer, Uterine Carcinoma

In brief

This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.

Key facts

Study ID

NCT07435987

Run by

Erasmus Medical Center

People needed

25

Starts

2026-05-01

Expected to finish

2027-12-01

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for primary radiotherapy including brachytherapy
• Written informed consent

You may not qualify if…

• Unable to give informed consent;
• Tumour extension in the lower 2/3rd of the vagina;
• Requiring a Geneva tandem with ovoids' size 13 mm in the first application for brachytherapy;
• Known nylon allergy.

Where it is running

• Erasmus Medical Center — Rotterdam, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.